Insider Transactions in Q2 2023 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 15
2023
|
Rishi Gupta Director |
SELL
Open market or private sale
|
Indirect |
359,713
-4.36%
|
$7,194,260
$20.98 P/Share
|
|
May 15
2023
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
359,713
-4.36%
|
$7,194,260
$20.98 P/Share
|
|
May 12
2023
|
Rishi Gupta Director |
SELL
Open market or private sale
|
Indirect |
43,200
-1.03%
|
$907,200
$21.64 P/Share
|
|
May 12
2023
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
43,200
-1.03%
|
$907,200
$21.64 P/Share
|
|
May 11
2023
|
Rishi Gupta Director |
SELL
Open market or private sale
|
Indirect |
80,000
-1.88%
|
$1,760,000
$22.26 P/Share
|
|
May 11
2023
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
80,000
-1.88%
|
$1,760,000
$22.26 P/Share
|
|
May 03
2023
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,752
-0.96%
|
$57,504
$2.65 P/Share
|
|
May 01
2023
|
Claire Poll General Counsel |
SELL
Open market or private sale
|
Direct |
80,376
-3.9%
|
$160,752
$2.58 P/Share
|
|
May 01
2023
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
455,536
-2.63%
|
$911,072
$2.58 P/Share
|
|
May 01
2023
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
455,528
-2.77%
|
$911,056
$2.58 P/Share
|
|
May 01
2023
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
77,424
-2.52%
|
$154,848
$2.58 P/Share
|